Commission commits to speeding up standardisation:
This article was originally published in Clinica
"Enormous improvement" could be made in the expediting of drafting European standards. That is the conclusion of a European Commission Communication on standardisation. To resource measures needed to speed progress, the Commission has proposed a "broader basis" for financing the European Standardisation Committee and the European Electrotechnical Standardisation Committee, CEN and CENELEC. Some consider this will mean that there will be a need for private funding. It has also said that there should be more extensive use of standards in EU legislation, including in the services sector, and continues to support the development of international standards and their adoption in the European system.
You may also be interested in...
A recent segment of CBS News “60 Minutes” discussing potential health benefits from probiotics was highly criticized by groups including the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association and the International Probiotics Association.
After a 12-month period that has seen Stada make significant investments in generics, biosimilars and consumer healthcare, CEO Peter Goldschmidt tells Generics Bulletin that the firm does not intend to stop there, as it pursues both organic and inorganic growth opportunities.
Samsung Bioepis is the latest company to stare down a lawsuit from Genentech over Avastin patents in the US. The Korean firm is aiming to be amongst the early biosimilar movers, after the market formed a year ago.